New Era in Antibiotic
Therapy Selection
AtbFinder - tailored selection of most effective antibiotic therapies for patients with serious bacterial infections.
TVG-Dx revolutionizes the way how antibiotics are selected
Clinical sample
Bacterial infections cause millions of preventable deaths
13.7 M
deaths due to bacterial infections annually
* approximately equal to the population of the state Illinoise
4
days
4
hours
The disruptive technology determines the most effective and affordable antibiotic regimen in less than 4 hours
Targeting the most hard-to-treat indications, with the current rate of antibiotic therapy failure approaching 50%
Growing Body of Evidence
Published in the Journal of Clinical Microbiology in 2023, AtbFinder continues to demonstrate the superiority of using this technology to select the most effective antibiotic regimens.
Learn more
Selecting antibiotics for the most hard-to-treat infections
Respiratory infections
VAP | CAP | COPD | CF
UTI
Recurrent UTI
SSTI
DFU | MRSA/VRSA- related SSTI
Our team
Global headquarters
180 Varick Street, fl6 New York, NY, 10014
United States
The AtbFinder® is under LDT approval